Videos

Sharing real-world patient data with researchers could help optimize clinical trials and drive discoveries in precision medicine, says Gaurav Sharma, senior director, global client partner at Cognizant.  

The digital divide affects patient access, but digital therapeutics and advocacy can break common barriers to care, says Tanisha Hill, founder and president of the Digital Health for Equitable Health Alliance.

Sal Lo, CEO of Jorie AI, discusses the company's policy of offering its automated billing and collections product to rural hospitals at a lower price to help them maximize reimbursements and sustain operations.

Anne Snowdon, chief scientific research officer at HIMSS, explains that interoperability is fundamental to enabling data-informed patient care decisions and is required for the use of AI and advanced analytics tools.

Ricardo Jorge Constantino, head of Clinical Innovation Europe at NTT DATA, describes innovation in clinical trials and measures to drive rapid adoption of insights from these trials into clinical practice.

The Change Healthcare ransomware attack may not have shaken cyber insurance opportunities, but how chain reaction cyberattacks can aggregate policy claims gives underwriters the shivers, explains Hartmut Mai, president of Cyberwrite.

Beginning her career in intellectual property law before attending medical school and working in research has helped her bring new healthcare ideas to market, says Dr. Nada Milosavljevic, Safe Health CMO.  

Cybercriminals are innovating quickly, but key learnings from the 2021 ransomware attack that caused a nationwide shutdown of Ireland's healthcare system are still highly relevant, says David Wall, CIO of Tallaght University Hospital.

As providers adopt IT solutions to streamline their documentation, they need to take accountability for shaping the underlying genAI, according to Michael Ristau, VP of global marketing and international growth at Solventum (formerly 3M Health Care).

Virtual care is comparable to in-person substance use disorder treatment and lowers the cost of treatment for substance misuse, said Dr. Yusuf Sherwani, CEO and cofounder of Pelago.